Grant, Call number PAR-25-183
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
National Institutes of Health
- , Add deadline: choose a calendar
- Institution applies
- Psychiatry, Psychopharmacology and
About
Test a pharmacological or neuromodulation intervention for a mental disorder in an early clinical trial. The R33 supports experimental therapeutics studies that measure clinical effects alongside evidence about the mechanism of the intervention.
Topics
Eligibility
Covers: The R33 funds early-stage clinical testing.
Eligible organizations based outside the US may apply.
Eligible organizations include universities, nonprofit research organizations and other categories specified in the announcement. Eligible organizations based outside the US may apply.
Source: simpler.grants.gov